Search Results - "Cöster, L"

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial by van Vollenhoven, RF, Dr, Ernestam, S, MD, Geborek, P, MD, Petersson, IF, MD, Cöster, L, MD, Waltbrand, E, MD, Zickert, A, MD, Theander, J, MD, Thörner, Å, MD, Hellström, H, MD, Teleman, A, MD, Dackhammar, C, MD, Akre, F, MD, Forslind, K, MD, Ljung, L, MD, Oding, R, MD, Chatzidionysiou, A, MD, Wörnert, M, RN, Bratt, J, MD

“…Summary Background New treatment strategies for early rheumatoid arthritis are evolving rapidly. We aimed to compare addition of conventional disease-modifying…”
Get full text

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register by Askling, J, Baecklund, E, Granath, F, Geborek, P, Fored, M, Backlin, C, Bertilsson, L, Cöster, L, Jacobsson, L T, Lindblad, S, Lysholm, J, Rantapää-Dahlqvist, S, Saxne, T, van Vollenhoven, R, Klareskog, L, Feltelius, N

“…Tumour necrosis factor (TNF) antagonists have proved effective as treatment against rheumatoid arthritis (RA), but the unresolved issue of whether the use of…”
Get more information

Belimumab may not prevent lupus nephritis in serologically active patients with ongoing non-renal disease activity by Sjöwall, C, Cöster, L

Get full text

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists by Askling, J, Fored, C M, Brandt, L, Baecklund, E, Bertilsson, L, Feltelius, N, Cöster, L, Geborek, P, Jacobsson, L T, Lindblad, S, Lysholm, J, Rantapää-Dahlqvist, S, Saxne, T, Klareskog, L

“…Background: Existing studies of solid cancers in rheumatoid arthritis (RA) reflect cancer morbidity up until the early 1990s in prevalent cohorts admitted to…”
Get full text

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists by Askling, J, Fored, C M, Baecklund, E, Brandt, L, Backlin, C, Ekbom, A, Sundström, C, Bertilsson, L, Cöster, L, Geborek, P, Jacobsson, L T, Lindblad, S, Lysholm, J, Rantapää-Dahlqvist, S, Saxne, T, Klareskog, L, Feltelius, N

“…Background: Patients with rheumatoid arthritis (RA) are at increased risk of malignant lymphomas, and maybe also of leukaemia and multiple myeloma. The effect…”
Get full text

Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists by Askling, Johan, Fored, C Michael, Brandt, Lena, Baecklund, Eva, Bertilsson, Lennart, Feltelius, Nils, Cöster, Lars, Geborek, Pierre, Jacobsson, Lennart T, Lindblad, Staffan, Lysholm, Jörgen, Rantapää-Dahlqvist, Solbritt, Saxne, Tore, van Vollenhoven, Ronald F, Klareskog, Lars

“…Objectives:The degree to which treatment with tumour necrosis factor (TNF) antagonists may be associated with increased risks for serious infections is…”
Get full text

Ten years with biologics: to whom do data on effectiveness and safety apply? by Simard, Julia F, Arkema, Elizabeth V, Sundström, Anders, Geborek, Pierre, Saxne, Tore, Baecklund, Eva, Coster, Lars, Dackhammar, Christina, Jacobsson, Lennart, Feltelius, Nils, Lindblad, Staffan, Rantapää-Dahlqvist, Solbritt, Klareskog, Lars, van Vollenhoven, Ronald F, Neovius, Martin, Askling, Johan

“…During the past decade, the position of biologics in the therapeutic armamentarium, the number of approved indications and the number of available biologics…”
Get full text

The core proteins of large and small interstitial proteoglycans from various connective tissues form distinct subgroups by Heinegård, D, Björne-Persson, A, Cöster, L, Franzén, A, Gardell, S, Malmström, A, Paulsson, M, Sandfalk, R, Vogel, K

“…Large and small proteoglycans were separately isolated from a number of connective tissues and compared to determine the extent of structural similarity. This…”
Get full text

Structural Characterization of Organic Multilayers on Silicon(111) Formed by Immobilization of Molecular Films on Functionalized Si−C Linked Monolayers by Böcking, Till, James, Michael, Coster, Hans G. L, Chilcott, Terry C, Barrow, Kevin D

“…Silicon(111)−H surfaces were derivatized with ω-functionalized alkenes in UV-mediated and thermal hydrosilylation reactions to give Si−C linked monolayers…”
Get full text

Proteoglycans of rabbit corneal stroma. Isolation and partial characterization by Gregory, J D, Cöster, L, Damle, S P

“…Proteoglycans extracted from rabbit corneal stroma can be separated by ion exchange and gel chromatography into two proteokeratan sulfates (PKS-I, PKS-II) and…”
Get full text

High-Pressure Experimental and DFT‑D Structural Studies of the Energetic Material FOX‑7 by Hunter, Steven, Coster, Paul L, Davidson, Alistair J, Millar, David I. A, Parker, Stewart F, Marshall, William G, Smith, Ronald I, Morrison, Carole A, Pulham, Colin R

“…This work reports the hydrostatic compression of the perdeuterated α-form of FOX-7 using neutron powder diffraction to follow the structural changes up to 4.58…”
Get full text

Binding of Transferrin to the Core Protein of Fibroblast Proteoheparan Sulfate by Fransson, Lars-Ake, Carlstedt, Ingemar, Coster, Lars, Malmstrom, Anders

“…Cell-surface-associated proteoheparan sulfate from confluent human skin fibroblasts appears to consist of two disulfide-bonded polypeptides of Mr≈ 90,000. The…”
Get full text

High-Pressure Neutron Powder Diffraction Study of ε‑CL-20: A Gentler Way to Study Energetic Materials by Konar, Sumit, Hunter, Steven, Morrison, Carole A, Coster, Paul L, Maynard-Casely, Helen E, Richardson, Jonathan G, Marshall, William G, Kleppe, Annette, Parker, Stewart F, Pulham, Colin R

“…High-pressure studies have been performed on the ε-form of the powerful explosive CL-20. Hydrostatic compression over the pressure range 0–12 GPa has been…”
Get full text

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission by Chatzidionysiou, Katerina, Turesson, Carl, Teleman, Annika, Knight, Ann, Lindqvist, Elisabet, Larsson, Per, Cöster, Lars, Forslind, Kristina, van Vollenhoven, Ronald, Heimbürger, Mikael

“…ObjectivesTreatment with tumour necrosis factor (TNF) blockers, once started as therapy for rheumatoid arthritis (RA), is usually continued indefinitely. The…”
Get full text

The sensitivity of somatic symptoms in post-stroke depression: response to Spalletta et al by Leentjens, A. F. G., de Coster, L., Lodder, J., Verhey, F. R. J.

Get full text

Ionic double layer of atomically flat gold formed on mica templates by Chilcott, Terry C., Wong, Elicia L.S., Coster, Hans G.L., Coster, Adelle C.F., James, Michael

“…Electrical impedance spectroscopy characterisations of gold surfaces formed on mica templates in contact with potassium chloride electrolytes were performed at…”
Get full text

Discovery of “punch-through” or membrane electrical breakdown and electroporation by Coster, Hans Gerard L

“…As part of a detailed study in Alex Hope's laboratory of the V-I characteristics of the membrane of the giant cells of Chara corallina, it was discovered that…”
Get full text

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab by Neovius, M, Arkema, E V, Olsson, H, Eriksson, J K, Kristensen, L E, Simard, J F, Askling, J

“…To compare drug survival on adalimumab, etanercept and infliximab in patients with rheumatoid arthritis (RA). Patients with RA (n=9139; 76% women; mean age 56…”
Get more information

Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden by Askling, Johan, Fored, C. Michael, Brandt, Lena, Baecklund, Eva, Bertilsson, Lennart, Cöster, Lars, Geborek, Pierre, Jacobsson, Lennart T., Lindblad, Staffan, Lysholm, Jörgen, Rantapää‐Dahlqvist, Solbritt, Saxne, Tore, Romanus, Victoria, Klareskog, Lars, Feltelius, Nils

“…Objective Because treatment with tumor necrosis factor (TNF) antagonists may increase the risk of tuberculosis (TB), and because knowledge of the risk of TB in…”
Get full text

The core protein of fibroblast proteoheparan sulphate consists of disulphide-bonded subunits by Cöster, L, Malström, A, Carlstedt, I, Fransson, L A

“…Fibroblast proteoheparan sulphate has a disulphide-bonded subunit structure. The core protein appears to consist of two polypeptides each of Mr 80 000-100 000…”
Get full text